CHIP buffers heterogeneous Bcl-2 expression levels to prevent augmentation of anticancer drug-resistant cell population. (Q51504173)

6 April 2018

title

CHIP buffers heterogeneous Bcl-2 expression levels to prevent augmentation of anticancer drug-resistant cell population. (English)

1 reference

6 April 2018

author name string

M Tsuchiya

1

1 reference

6 April 2018

Y Nakajima

2

1 reference

6 April 2018

T Waku

3

1 reference

6 April 2018

H Hiyoshi

4

1 reference

6 April 2018

T Morishita

5

1 reference

6 April 2018

R Furumai

6

1 reference

6 April 2018

Y Hayashi

7

1 reference

6 April 2018

H Kishimoto

8

1 reference

6 April 2018

K Kimura

9

1 reference

6 April 2018

J Yanagisawa

10

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 December 2014

1 reference

6 April 2018

published in

Oncogene

1 reference

6 April 2018

volume

34

1 reference

6 April 2018

issue

35

1 reference

6 April 2018

page(s)

4656-4663

1 reference

6 April 2018

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Breast cancer: origins and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

An analogy between the evolution of drug resistance in bacterial communities and malignant tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

p-Glycoprotein ABCB5 and YB-1 expression plays a role in increased heterogeneity of breast cancer cells: correlations with cell fusion and doxorubicin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Molecular mechanisms of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

VDAC regulation by the Bcl-2 family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

The BCL-2 protein family: opposing activities that mediate cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Protein degradation and protection against misfolded or damaged proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Overexpression of the cochaperone CHIP enhances Hsp70-dependent folding activity in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Hsp90 as a capacitor for morphological evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Hsp90 as a capacitor of phenotypic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

On the role of 17 alpha-estradiol and 17 beta-estradiol in the proliferation of MCF7 and T47D-A11 human breast tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Subpopulations of MCF7 cells separated by Percoll gradient centrifugation: a model to analyze the heterogeneity of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Epithelial and fibroblast cell lines cultured from the transgenic BigBlue rat: an in vitro mutagenesis assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

A negative regulatory element in the bcl-2 5'-untranslated region inhibits expression from an upstream promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

NF-kappaB1 (p50) homodimers contribute to transcription of the bcl-2 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

The retinoblastoma protein binds the promoter of the survival gene bcl-2 and regulates its transcription in epithelial cells through transcription factor AP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

BP1 transcriptionally activates bcl-2 and inhibits TNFalpha-induced cell death in MCF7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Sequence analysis of mutations and translocations across breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Cancer stem cells: impact, heterogeneity, and uncertainty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Intra-tumour heterogeneity: a looking glass for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Quality control and fate determination of Hsp90 client proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

CA repeats in the 3'-untranslated region of bcl-2 mRNA mediate constitutive decay of bcl-2 mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.387

Identification of a p53-dependent negative response element in the bcl-2 gene

31 March 2020

1 reference

12 December 2020

Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer

1 reference

12 December 2020

Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance

1 reference

12 December 2020

Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.

1 reference

12 December 2020

Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1

1 reference

12 December 2020

Raf-1 and Bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance

1 reference

12 December 2020

Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2

1 reference

12 December 2020

Relation of in vitro properties to tumorigenicity for a series of sublines of the human breast cancer cell line MCF-7

1 reference

12 December 2020

The effect of cis-diamminedichloroplatinum (II) on cultured human lymphoma cells and its therapeutic implications.

1 reference

12 December 2020

Identifiers

DOI

10.1038/ONC.2014.387

1 reference

6 April 2018

1 reference

6 April 2018